Jahn, Janosch
Reisenauer, Christl http://orcid.org/0000-0002-9676-5395
Schoenfisch, Birgitt
Amend, Bastian
Brucker, Sara Yvonne
Andress, Juergen
Funding for this research was provided by:
Eberhard Karls Universität Tübingen
Article History
Received: 28 July 2021
Accepted: 18 October 2021
First Online: 28 October 2021
Declarations
:
: Janosch Jahn, Christl Reisenauer, Birgitt Schoenfisch, Bastian Amend, Juergen Andress: no conflict of interest. Sara Y Brucker: personal fees from Pfizer, personal fees from Novartis, personal fees from Teva, personal fees from MSD, personal fees from AstraZeneca, personal fees from Storz, personal fees from Roche.
: Institutional approval: Independent Review Board (IRB)—Eberhard Karls University Hospital: 923/2018BO2.
: Not applicable.
: Not applicable.